BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36625831)

  • 1. Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia.
    Cole PD; Kim SY; Li Y; Schembri A; Kelly KM; Sulis ML; Vrooman L; Welch JJG; Ramjan S; Silverman LB; Sands SA
    Support Care Cancer; 2023 Jan; 31(2):109. PubMed ID: 36625831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Hardy KK; Kairalla JA; Gioia AR; Weisman HS; Gurung M; Noll RB; Hinds PS; Hibbitts E; Salzer WL; Burke MJ; Winick NJ; Embry L
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30350. PubMed ID: 37129114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.
    Cheung YT; Edelmann MN; Mulrooney DA; Green DM; Chemaitilly W; John N; Robison LL; Hudson MM; Krull KR
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1259-67. PubMed ID: 27345588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
    Vasquez P; Escalante J; Raghubar KP; Kahalley LS; Taylor OA; Moore IK; Hockenberry MJ; Scheurer ME; Brown AL
    Pediatr Blood Cancer; 2022 May; 69(5):e29507. PubMed ID: 34889514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring neurocognitive functioning in childhood cancer survivors: evaluation of CogState computerized assessment and the Behavior Rating Inventory of Executive Function (BRIEF).
    Balsamo LM; Mitchell HR; Ross W; Metayer C; Hardy KK; Kadan-Lottick NS
    BMC Psychol; 2019 May; 7(1):26. PubMed ID: 31046815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation.
    Jacola LM; Conklin HM; Krull KR; Pei D; Cheng C; Reddick WE; Pui CH; Jeha S
    J Clin Oncol; 2022 Dec; 40(36):4218-4227. PubMed ID: 36322880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome.
    Gandy K; Hall L; Krull KR; Esbensen AJ; Rubnitz J; Jacola LM
    Cancer Med; 2024 Feb; 13(3):e6842. PubMed ID: 38240104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
    Krull KR; Cheung YT; Liu W; Fellah S; Reddick WE; Brinkman TM; Kimberg C; Ogg R; Srivastava D; Pui CH; Robison LL; Hudson MM
    J Clin Oncol; 2016 Aug; 34(22):2644-53. PubMed ID: 27269941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
    Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
    JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapy.
    Iijima M; Liu W; Panetta JC; Hudson MM; Pui CH; Srivastava DK; Krull KR; Inaba H
    Cancer; 2021 Sep; 127(17):3202-3213. PubMed ID: 33914910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
    Nassar SL; Conklin HM; Zhou Y; Ashford JM; Reddick WE; Glass JO; Laningham FH; Jeha S; Cheng C; Pui CH
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28130818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic pain and neurocognitive functioning in children treated for acute lymphoblastic leukemia.
    Partanen M; Alberts NM; Conklin HM; Krull KR; Pui CH; Anghelescu DA; Jacola LM
    Pain; 2022 Jun; 163(6):1070-1077. PubMed ID: 34813516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Working memory training in survivors of pediatric cancer: a randomized pilot study.
    Hardy KK; Willard VW; Allen TM; Bonner MJ
    Psychooncology; 2013 Aug; 22(8):1856-65. PubMed ID: 23203754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.